These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20639674)

  • 21. Management of scleroderma-related end-stage renal disease with automated peritoneal dialysis.
    Pavan M; Aiyangar A; Chaudhari A; Rajputh P; Ranganath R; Babulal SA
    Iran J Kidney Dis; 2010 Apr; 4(2):162-3. PubMed ID: 20404430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients.
    Steiner S; Schaller G; Puttinger H; Födinger M; Kopp CW; Seidinger D; Grisar J; Hörl WH; Minar E; Vychytil A; Wolzt M; Sunder-Plassmann G
    Am J Kidney Dis; 2005 Sep; 46(3):520-8. PubMed ID: 16129215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for vascular complications in patients on peritoneal dialysis.
    Arima H; Nakamoto H; Okada S; Inoue T; Kobayashi K; Shoda J; Ikeda N; Kanno Y; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():192-7. PubMed ID: 16983968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [How to start dialysis. Peritoneal dialysis--clinical aspects].
    Quarello F
    G Ital Nefrol; 2008; 25 Suppl 41():S25-6. PubMed ID: 18473316
    [No Abstract]   [Full Text] [Related]  

  • 26. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with chronic peritoneal dialysis in infants.
    Qamar IU; Balfe JW
    Child Nephrol Urol; 1991; 11(3):159-64. PubMed ID: 1723351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Nephrol Dial Transplant; 2009 Dec; 24(12):3826-33. PubMed ID: 19574337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient selection to peritoneal dialysis versus hemodialysis according to comorbid conditions.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):20-6. PubMed ID: 1442771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-tailored prescription of PD.
    Twardowski ZJ
    EDTNA ERCA J; 1997; 23(3):4-13. PubMed ID: 9664000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.
    Rodriguez-Iturbe B; Correa-Rotter R
    Expert Opin Pharmacother; 2010 Nov; 11(16):2687-98. PubMed ID: 20426701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular comorbidity and mortality in patients starting peritoneal dialysis: an American midwestern center experience.
    Tan SH; Prowant BF; Khanna R; Nolph KD; Twardowski ZJ
    Adv Perit Dial; 2001; 17():142-7. PubMed ID: 11510263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritoneal dialysis in renal failure associated with spinal cord injury.
    Vaziri ND; Lopez G; Nikakhtar B; Gordon S; Penera N
    J Am Paraplegia Soc; 1984 Oct; 7(4):63-5. PubMed ID: 6512526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of dialysis modality (PD and HD) on cardiac morphology and functions in chronic kidney disease patients at very high cardiovascular risk.
    Krajewska M; Kosmala W; Weyde W; Madziarska K; Porazko T; Kopec W; Klak R; Penar J; Kusztal M; Watorek E; Golebiowski T; Klinger M
    Nephrol Dial Transplant; 2008 Feb; 23(2):768-9. PubMed ID: 18029367
    [No Abstract]   [Full Text] [Related]  

  • 38. [Semi-continuous peritoneal dialysis - an advantageous modification of the peritoneal dialysis technic].
    Kleint V; Stradtmann H; Klinger H; Palm B; Frenkel I
    Z Urol Nephrol; 1981 Apr; 74(4):299-304. PubMed ID: 7269815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent peritoneal dialysis. A study of medical complications occurring in 16 patients.
    Cangiano JL; Kuruvila T; Kastagir B; Vertes V
    Ohio State Med J; 1969 Jul; 65(7):681-7. PubMed ID: 4309002
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors for mortality in diabetic peritoneal dialysis patients.
    Chung SH; Han DC; Noh H; Jeon JS; Kwon SH; Lindholm B; Lee HB
    Nephrol Dial Transplant; 2010 Nov; 25(11):3742-8. PubMed ID: 20466690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.